WahanaRiau.com - Philogen

Berita Politik Peristiwa Ekonomi Otomotif Olahraga Teknologi Gaya Hidup Travel Video Media OutReach Globenewswire Advertorial Pilihan Editor Terpopuler Indeks

Berita
Peristiwa
Politik
Ekonomi
Teknologi
Otomotif
Olahraga
Gaya Hidup
Travel
More

Philogen

Index

Globenewswire

Nidlegy™ Phase III PIVOTAL Trial Meets the Study’s Primary Objective Demonstrating Statistically Significant and Clinically Meaningful Improvement in Recurrence-Free Survival for Patients with Locally Advanced Fully Resectable Melanoma

Senin, 16 Oktober 2023 - 22:07:00 Wib

Philogen

Nidlegy™ Phase III PIVOTAL Trial Meets the Study’s Primary Objective Demonstrating Statistically Significant and Clinically Meaningful Improvement in Recurrence-Free Survival for Patients with Locally Advanced Fully Resectable Melanoma

Terpopuler

Global Degrees, Closer to Home: SIM's Guide for Parents Choosing UK, Australian and US Qualifications in Singapore
Dibaca: 105 Kali

Creative Secondary School Celebrates 20 Years of Educational Excellence with Open Day 2026: "World of Possibilities"
Dibaca: 103 Kali

ATOMS, Led by Travis Kalanick, Secures $1.7B to Power the Future of Food Delivery with ProKitchens in Europe
Dibaca: 114 Kali

De Beers Group Advances Building Forever Goals with Significant Progress on Livelihoods, Nature, Climate and Provenance
Dibaca: 116 Kali

Japanese Bag Brand pionunnal Makes Its Overseas Debut at Takashimaya Singapore
Dibaca: 105 Kali

Terkini

Global Degrees, Closer to Home: SIM's Guide for Parents Choosing UK, Australian and US Qualifications in Singapore

APAC Medical Cost Growth Projected to Slow to 9.7% in 2027, Aon Report

Creative Secondary School Celebrates 20 Years of Educational Excellence with Open Day 2026: "World of Possibilities"

ATOMS, Led by Travis Kalanick, Secures $1.7B to Power the Future of Food Delivery with ProKitchens in Europe

De Beers Group Advances Building Forever Goals with Significant Progress on Livelihoods, Nature, Climate and Provenance

Philogen

Nidlegy™ Phase III PIVOTAL Trial Meets the Study’s Primary Objective Demonstrating Statistically Significant and Clinically Meaningful Improvement in Recurrence-Free Survival for Patients with Locally Advanced Fully Resectable Melanoma

Terpopuler

Global Degrees, Closer to Home: SIM's Guide for Parents Choosing UK, Australian and US Qualifications in Singapore Dibaca: 105 Kali

Creative Secondary School Celebrates 20 Years of Educational Excellence with Open Day 2026: "World of Possibilities" Dibaca: 103 Kali

ATOMS, Led by Travis Kalanick, Secures $1.7B to Power the Future of Food Delivery with ProKitchens in Europe Dibaca: 114 Kali

De Beers Group Advances Building Forever Goals with Significant Progress on Livelihoods, Nature, Climate and Provenance Dibaca: 116 Kali

Japanese Bag Brand pionunnal Makes Its Overseas Debut at Takashimaya Singapore Dibaca: 105 Kali

Terkini

Global Degrees, Closer to Home: SIM's Guide for Parents Choosing UK, Australian and US Qualifications in Singapore

APAC Medical Cost Growth Projected to Slow to 9.7% in 2027, Aon Report

Creative Secondary School Celebrates 20 Years of Educational Excellence with Open Day 2026: "World of Possibilities"

ATOMS, Led by Travis Kalanick, Secures $1.7B to Power the Future of Food Delivery with ProKitchens in Europe

De Beers Group Advances Building Forever Goals with Significant Progress on Livelihoods, Nature, Climate and Provenance

Global Degrees, Closer to Home: SIM's Guide for Parents Choosing UK, Australian and US Qualifications in Singapore
Dibaca: 105 Kali

Creative Secondary School Celebrates 20 Years of Educational Excellence with Open Day 2026: "World of Possibilities"
Dibaca: 103 Kali

ATOMS, Led by Travis Kalanick, Secures $1.7B to Power the Future of Food Delivery with ProKitchens in Europe
Dibaca: 114 Kali

De Beers Group Advances Building Forever Goals with Significant Progress on Livelihoods, Nature, Climate and Provenance
Dibaca: 116 Kali

Japanese Bag Brand pionunnal Makes Its Overseas Debut at Takashimaya Singapore
Dibaca: 105 Kali